The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.
Able to understand and provide informed consent 18 years and older Overweight or obesity (BMI ≥ 27.5) Not 6 months postpartum Not planning to become pregnant in the next 7 months Have a smartphone that is compatible with Noom's mobile app Breast cancer survivor with stage I, II, or III Completed active treatment (e.g, surgery, chemo, radiation, etc.) > 6 months ago
Exclusion Criteria:
Inability or unwillingness of a participant to give written informed consent Currently pregnant or < 6 months postpartum Plans to become pregnant within the next 7 months Stage IV, metastatic cancer or DCIS Currently taking insulin Uncontrolled hypertension
